ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,659.60
      -2.28%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.345
      0.28%
      Bitcoin
      57,194.77
      -0.27%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Innate Pharma SA (IPHA)

      7. Innate Pharma SA (IPHA) Financials

      Innate Pharma SA

      Innate Pharma SA (IPHA)

      NASDAQ
      2.095
      -0.065
      (-3.01%)
      Closed July 12 4:00PM
      Delayed by 15 minutes
      2.095
      0.00
      (0.00%)
      After Hours: 5:01PM
      Delayed by 15 minutes

      Innate Pharma SA Financial Summary

      The current IPHA market cap is 168.55M. The company's latest EPS is EUR -0.0941 and P/E is -21.68.

      Income Statement

      Annual Quarterly
      Quarter End
      EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
      Total Revenue
      Operating Income
      Net Income
      Year End December 30 2023 20192020202120222023
      EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
      Total Revenue 85.81M71.32M26.5M57.89M61.64M
      Operating Income -27.05M-62.08M-54.98M-57.53M-12.67M
      Net Income -20.76M-63.98M-52.81M-58.1M-7.57M

      Balance Sheet

      Annual Quarterly
      Quarter End
      EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
      Total Assets
      Total Liabilities
      Total Equity
      Year End December 30 2023 20192020202120222023
      EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
      Total Assets 401.36M307.42M267.5M207.86M184.19M
      Total Liabilities 183.95M151.45M160.06M153.71M132.29M
      Total Equity 217.42M155.98M107.44M54.15M51.9M

      Cash Flow

      Annual Quarterly
      Quarter End
      EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
      Operating
      Investing
      Financing
      Year End December 30 2023 20192020202120222023
      EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
      Operating 34.92M-51.77M-58.46M-19.15M-32.56M
      Investing -62.12M-13.37M-917k1.88M20.63M
      Financing 77.77M-1.18M26.82M-1.83M-1.97M

      Stats and Ratios

      Market Cap 168.55M
      Price to Earnings Ratio -21.68
      Price to Sales Ratio 2.66
      Price to Cash Ratio 2.32
      Price to Book Ratio 3.16
      Dividend Yield -

      Share Statistics

      Shares Outstanding 80.45M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 1.93 (63.91%)

      Company Info

      Company Name Innate Pharma SA
      Address 117 avenue de luminy
      marseille, bouches-du-rhone 13009
      Website https://www.innate-pharma.com
      Industry biological pds,ex diagnstics (2836)